A new test may predict the risk of the most common type of breast cancer spreading to other organs.
The effectiveness of the test, which counts the number of locations in tumours where tumour cells may invade blood vessels, was measured by using it on 500 breast tumour specimens collected over 20 years.
The test was found to be more accurate at measuring metastatic risk than the leading breast cancer prognosis on the market.
Study author Thomas Rohan says the test can help doctors identify which patients should and shouldn’t receive aggressive therapy.
Read more at Albert Einstein College of Medicine